A New Mesothelioma Risk Score for Patients with Pre-Treated Malignant Pleural Mesothelioma
| |

A New Mesothelioma Risk Score for Patients with Pre-Treated Malignant Pleural Mesothelioma

ByHolly Zink

There has been some encouraging news for patients with pre-treated malignant pleural mesothelioma. A new mesothelioma risk score has been developed for pre-treated mesothelioma patients. The new score is predictive of patient outcomes and it informs a better treatment strategy for second-line treatment. Results come from an international team of oncologists from Italy, the United Kingdom, Switzerland, Greece, and Spain. The Pre-Treated Mesothelioma Patient The young (65 years or younger) mesothelioma patients who have received treatment once before are often called “pre-treated.” Clinicians often have more personalized data available for these patients. But there are many different factors that affect the clinician’s treatment strategy. The best treatment for pre-treated mesothelioma patients is still up for debate. Many clinicians use a…

Treatment Combination for Younger Pre-Treated Mesothelioma Patients

Treatment Combination for Younger Pre-Treated Mesothelioma Patients

ByHolly Zink

There are many systemic therapies recommended for mesothelioma patients. Different therapies may work best for different patient populations. Different therapies may work better for older versus younger patients. Or, patients who have received treatment before. An international team of clinicians published a new study on this topic. They found a treatment strategy that works best for younger pre-treated patients. The Young (65 years or younger) and Pre-Treated Patient Mesothelioma patients who have received treatment once before, are often called “pre-treated.” Clinicians often have more personalized data available for these patients. This affects the clinician’s treatment strategy. A new study compared the data from nine different mesothelioma clinical trials. These clinical trials spanned standard and experimental treatment options. The results are…